HHHisaaki Hirose

Hisaaki Hirose

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hisaaki Hirose has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Single L17E Mutation Switches the Membrane Disruption Mechanism of the Spider Venom Peptide M-lycotoxin

    by Miki Ohno, Yoshimasa Kawaguchi, Hisaaki Hirose, Shiroh Futaki, Wataru Shinoda

    Membrane-active peptides (MAPs) disrupt lipid bilayers through mechanisms that depend sensitively on amino acid sequence, yet the molecular determinants governing membrane pore formation remain incompletely understood. The spider-venom peptide M-lycotoxin exhibits strong membrane-disruptive activity, whereas a single substitution of Leu17 with glutamate (L17E) markedly reduces cytotoxicity. Here, we employed microsecond-scale all-atom molecular dynamics simulations to investigate how this mutation alters the membrane disruption pathway. The wild-type (WT) peptide preserves strong amphiphilicity and stable α-helicity, enabling deep insertion into the membrane. In multiple independent simulations, WT peptides spontaneously nucleated membrane defects that evolved into toroidal pores stabilized by inward bending of lipid headgroups and cooperative insertion of a small number of peptides. These pores contain continuous water columns and permit transient ion permeation. In contrast, the L17E mutation disrupts amphiphilicity and reduces helical stability, weakening peptide-membrane coupling. As a result, spontaneous pore formation is not observed. Under an applied electric field used to accelerate rare membrane penetration events in simulations, the mutant adopts only a largely nonconductive transmembrane configuration that does not develop into cooperative pore assemblies. These results indicate that the L17E mutation shifts the membrane disruption pathway from cooperative toroidal pore formation to a nonconductive transmembrane state, providing a molecular explanation for the reduced cytotoxicity of the mutant.

  • Open Access

    Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides

    by Yurina Araki, Tomoka Takatani-Nakase, Sohei Ninomiya, Mitsuyo Matsumoto, Hisaaki Hirose, Yoshimasa Kawaguchi, Daisuke Fujiwara, Masataka Michigami, Hironori Katoh, Takehiko Wada, et al.

    Breast cancer remains one of the most prevalent cancers among women, with triple-negative breast cancer (TNBC), lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, accounting for approximately 15-20% of all patients with breast cancer. TNBC is notably aggressive, with a high invasive, metastatic, and recurrence potential. In this study, we found that the migration and invasion capabilities of MDA-MB-231 cells, derived from human TNBC, were strongly influenced by the serum concentration. Transwell assays revealed that TNBC cell migration varied depending on the fetal bovine serum (FBS) level, with an optimal concentration that substantially enhanced migration and invasion. In contrast, non-TNBC MCF-7 cells exhibited no such serum-dependent migration pattern. In addition to data-independent acquisition (DIA) phosphoproteomic analysis for understanding the mechanisms, the cellular uptake of the flock house virus coat (35-49) peptide, a type of arginine-rich cell-penetrating peptide with serum-dependent cellular uptake efficacy, was significantly increased under the optimal serum conditions, which induces cell migration, leading to efficient delivery of apoptosis-inducible peptide and TNBC-killing activity. Our findings highlight the critical role of serum concentration in regulating TNBC behavior and offer insights into leveraging serum-responsive delivery systems for targeted breast cancer therapy.


  • SARS-CoV-2 inhibition through mRNA delivery using engineered extracellular vesicles displaying the spike protein

    by Yuna Nakagawa, Yoshimasa Kawaguchi, Hisaaki Hirose, Takao Hashiguchi, Joseph Lee, Akitsu Hotta, Jun Kawamoto, Michihito Sasaki, Hirofumi Sawa, Shiroh Futaki


  • Membrane Repair Proteins as Negative Regulators of Cytosolic Delivery Using Attenuated Cationic Lytic Peptide L17E and Cell-Penetrating Peptides: Differences and Similarities

    by Masashi Kuriyama, Yoshimasa Kawaguchi, Shinji Ito, Junko Satoh, Hisaaki Hirose, Shiroh Futaki

    Cytosolic delivery of functional macromolecules is beneficial for intracellular targeting. Although numerous intracellular delivery methods have been developed, the biological factors that govern their efficacy remain poorly understood, thereby limiting further advancement of existing approaches. L17E is an attenuated cationic amphiphilic lytic (ACAL) peptide developed by our research group that facilitates the cytosolic delivery of macromolecules, including antibodies and functional proteins. The L17E peptide exhibits varying levels of cytosolic delivery even within a single cell line, suggesting heterogeneity in the cellular sensitivity to the delivery process. Based on the hypothesis that the specific proteins contribute to this variability, HeLa cells were sorted into L17E-sensitive and L17E-insensitive populations. Comparative proteome analysis of the membrane fractions of these two groups revealed that annexin A2, a membrane repair-related protein, was more abundant in L17E-insensitive cells. Time-lapse imaging and knockdown experiments indicated that annexin A2 negatively regulates L17E-mediated cytosolic delivery by sealing the plasma membrane regions permeabilized by the L17E peptide. To assess whether membrane repair factors also influence cytosolic delivery via conventional cell-penetrating peptides (CPPs), we examined the roles of repair-related proteins. We found that the endosomal sorting complex required for transport (ESCRT) suppressed the cytosolic translocation of the CPPs, whereas annexin A2 did not. These findings suggest that the L17E peptide and the CPPs utilize distinct membrane repair-associated pathways during delivery and that the expression levels of these repair factors affect delivery efficiency. Modulating such factors may therefore provide a strategy for enhancing peptide-based cytosolic delivery systems.


  • Polysaccharide-Based Coacervate Microgel Bearing Cationic Peptides That Achieve Dynamic Cell-Membrane Structure Alteration and Facile Cytosolic Infusion of IgGs

    by Junya Michibata, Yoshimasa Kawaguchi, Hisaaki Hirose, Akiko Eguchi, Sayaka Deguchi, Kazuo Takayama, Wei Xu, Takuro Niidome, Yoshihiro Sasaki, Kazunari Akiyoshi, et al.

    Conjugates of the biocompatible polysaccharide pullulan with a cell membrane permeabilizing peptide L17E (PL-L17Es) were prepared with the aim of producing complex coacervates with pronounced intracellular antibody (IgG) delivery activity and stable structures. Coacervates with diameters of a few μm were formed simply by mixing PL-L17Es with IgG labeled with negatively charged fluorescent moieties of Alexa Fluor 488 [IgG(AF488)]. The coacervate resulted in a pronounced cytosolic infusion of IgG(AF488) and IgG binding to the target proteins inside the cell. The droplet structures were maintained even under high salt conditions, and the fluorescence in the droplet was not recovered after photobleaching, suggesting the formation of complex coacervate microgels. Dynamic changes in cell membrane structure to entrap the coacervate microgels were captured by confocal and electron microscopy, resulting in cytosolic IgG infusion. The use of M-lycotoxin instead of L17E resulted in a coacervate microgel with marked IgG delivery activity even in the presence of serum. Successful IgG delivery to primary hepatocytes, undifferentiated induced pluripotent stem (iPS) cells, and iPS cell-derived intestinal epithelial cells was also achieved. The construction of complex coacervate microgels with design flexibility and the validity of intracellular IgG delivery with high salt stability were thus demonstrated.


  • ATP2B4 is an essential gene for epidermal growth factor‐induced macropinocytosis in A431 cells

    by Shunsuke Yoshie, Masashi Kuriyama, Masashi Maekawa, Wei Xu, Takuro Niidome, Shiroh Futaki, Hisaaki Hirose

    Macropinocytosis (MPC) is a large‐scale endocytosis pathway that involves actin‐dependent membrane ruffle formation and subsequent ruffle closure to generate macropinosomes for the uptake of fluid‐phase cargos. MPC is categorized into two types: constitutive and stimuli‐induced. Constitutive MPC in macrophages relies on extracellular Ca2+ sensing by a calcium‐sensing receptor. However, the link between stimuli‐induced MPC and Ca2+ remains unclear. Here, we find that both intracellular and extracellular Ca2+ are required for epidermal growth factor (EGF)‐induced MPC in A431 human epidermoid carcinoma cells. Through investigation of mammalian homologs of coelomocyte uptake defective (CUP) genes, we identify ATP2B4, encoding for a Ca2+ pump called the plasma membrane calcium ATPase 4 (PMCA4), as a Ca2+‐related regulator of EGF‐induced MPC. Knockout (KO) of ATP2B4, as well as depletion of extracellular/intracellular Ca2+, inhibited ruffle closure and macropinosome formation, without affecting ruffle formation. We demonstrate the importance of PMCA4 activity itself, independent of interactions with other proteins via its C‐terminus known as a PDZ domain‐binding motif. Additionally, we show that ATP2B4‐KO reduces EGF‐stimulated Ca2+ oscillation during MPC. Our findings suggest that EGF‐induced MPC requires ATP2B4‐dependent Ca2+ dynamics.


  • Open Access

    Light-controllable cell-membrane disturbance for intracellular delivery

    by Wenting Huo, Koji Miki, Huiying Mu, Takashi Osawa, Harumi Yamaguma, Yuuya Kasahara, Satoshi Obika, Yoshimasa Kawaguchi, Hisaaki Hirose, Shiroh Futaki, et al.

    A light-controllable delivery method based on the tetraphenylethene derivative was developed to improve the intracellular delivery of charged molecules. It does not require chemical modification of drugs and is applicable to a variety of cell lines.


  • Liquid Droplet-Mediated Formulation of Lipid Nanoparticles Encapsulating Immunoglobulin G for Cytosolic Delivery

    by Yusuke Hirai, Yoshimasa Kawaguchi, Chisato Kasahara, Hisaaki Hirose, Shiroh Futaki

    Antibodies are promising biopharmaceuticals that offer new therapeutic options for diseases. Since antibodies are membrane impermeable, approaches that allow immunoglobulin Gs (IgGs) to access intracellular therapeutic targets would open new horizons in antibody therapies. Lipid nanoparticles (LNPs) are among the classes of vectors that deliver biopharmaceuticals into cells. Using liquid droplets formed by IgG and polyglutamate, we report here a unique approach to forming LNPs containing IgG via liquid droplets formed in the presence of polyglutamic acid (polyE). The addition of polyE promoted the formation of smaller LNPs with cationic lipids than in its absence, and the formed LNPs were much more efficient in cytosolic IgG delivery and targeting of cellular proteins. This approach also allows for the encapsulation of intact IgG without the need for chemical or sequence modification. The intracellularly delivered IgG retained its target binding ability, as demonstrated by labeling of nuclear pore complex and HRas-GFP and inhibition of antiapoptotic cell death by phosphorylated Akt protein in live cells.


  • Open Access

    Inkjet-Based Intracellular Delivery System that Effectively Utilizes Cell-Penetrating Peptides for Cytosolic Introduction of Biomacromolecules through the Cell Membrane

    by Mika Omura, Kenta Morimoto, Yurina Araki, Hisaaki Hirose, Yoshimasa Kawaguchi, Yukiya Kitayama, Yuto Goto, Atsushi Harada, Ikuo Fujii, Tomoka Takatani-Nakase, et al.

    In the drug delivery system, the cytosolic delivery of biofunctional molecules such as enzymes and genes must achieve sophisticated activities in cells, and microinjection and electroporation systems are typically used as experimental techniques. These methods are highly reliable, and they have high intracellular transduction efficacy. However, a high degree of proficiency is necessary, and induced cytotoxicity is considered as a technical problem. In this research, a new intracellular introduction technology was developed through the cell membrane using an inkjet device and cell-penetrating peptides (CPPs). Using the inkjet system, the droplet volume, droplet velocity, and dropping position can be accurately controlled, and minute samples (up to 30 pL/shot) can be carried out by direct administration. In addition, CPPs, which have excellent cell membrane penetration functions, can deliver high-molecular-weight drugs and nanoparticles that are difficult to penetrate through the cell membrane. By using the inkjet system, the CPPs with biofunctional cargo, including peptides, proteins such as antibodies, and exosomes, could be accurately delivered to cells, and efficient cytosolic transduction was confirmed.


  • Open Access

    Disulfiram encapsulated in polymer nanoparticles ameliorates thioacetamide-induced liver injury

    by Wei Xu, Yuta Kadoya, Kaito Sennari, Waliul Islam, Tianli Zhang, Tomohiro Sawa, Fumika Akizuki, Hisaaki Hirose, Shiroh Futaki, Yukio Fujiwara, et al.